H.C. Wainwright Reiterates Buy Rating on Alto Neuroscience (ANRO)

March 18, 2026 7:57 AM

H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating and $50.00 price target on Alto Neuroscience (NYSE: ANRO).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found